GTC Biotherapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GTC Biotherapeutics

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: DewDiligence_on_SI	5/4/2007 5:14:46 PM
	of 135

What is GTC’s Business Model? The simplified version: “We are strongly of the opinion that, for any therapeutic protein, we can be the low-cost provider.” —CEO Geoffrey Cox (from the Nov 2006 Lazard webcast) The unabridged version: “We see ourselves primarily as a production company in the follow-on biologics and second generation area with established pre-clinical development capabilities. We anticipate the commercialization will primarily be the responsibility of our partners… We are also able to provide a strong intellectual property position that is independent of the cell culture process patents including the patents commonly referred to as Cabilly that could otherwise inhibit development in this area.” —CEO Geoffrey Cox (from GTC’s 1Q07 conference call)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next